Clinical and socio-demographic profile of pneumonia in children aged 2 months to 5 years
Abstract
Among the common childhood illnesses, pneumonia is a substantial cause of morbidity and mortality in children throughout the world. Approximately, 150 million episodes of childhood pneumonia are reported every year, out of which 95% are from developing countries. In addition, socioeconomic and environmental factors like overcrowding, air pollution, passive smoking, practice of bottle feeding etc., contribute to the significant rise in incidence of pneumonia during recent years. The known factors affecting mortality are malnutrition, inadequate vaccination, illiteracy and lack of exclusive breast feeding.Pneumonia is one of the most prevalent Pediatric infections, and it is a leading cause of morbidity and mortality in children all over the world. Every year, approximately 150 million cases of childhood pneumonia are reported, with 95 percent of cases coming from underdeveloped nations. Furthermore, socioeconomic and environmental variables like as overcrowding, air pollution, passive smoking, and the practice of bottle feeding, among others, have contributed to the large increase in pneumonia incidence in recent years. Malnutrition, inadequate immunization, illiteracy, and a lack of exclusive breast feeding are all documented variables that contribute to mortality.A total of 120 children in the age group of 2 months to 5 years, diagnosed with Pneumonia as per standard definition were enrolled in the study. Detailed history was taken including socio demographic factors and…
Read the paper
Related studies
- Tobacco and COPD: presenting the World Health Organization (WHO) Tobacco Knowledge Summary
- Comparative effects of e-cigarette smoking on periodontal status, salivary pH, and cotinine levels
- Association between exposure to environmental pollutants and increased oral health risks, a comprehensive review
- Influence of gestational window on offspring vascular health in rodents with in utero exposure to electronic cigarettes
- Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials
- Nicotine in electronic cigarettes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.